Have a personal or library account? Click to login
Risk Factors for Weaning Failure in COVID-19 Patients Cover

Figures & Tables

Characteristics of participants according to weaning outcome_

Weaning Success (N=61)Weaning Failure (N=97)P Value
Age, years62.39 (59.1–65.66)67.41 (65.22–69.61)0.02
Men, n (%)42 (68.9)61 (62.96)0.49
APACHE II score Day 014.87 (13.46–16.28)16.46 (15.19–17.72)0.12
SOFA score Day 07.2 (6.67–7.75)8.24 (7.70–8.77)0.02
Heart failure, n (%)4 (6.5)18 (18.5)0.03
Diabetes mellitus, n (%)13 (21.3)14 (14.4)0.28
Hypertension, n (%)31 (50.8)46 (47.4)0.74
COPD, n (%)4 (6.5)20 (20.6)0.02
Immunosuppression, n (%)2 (3.2)12 (12.3)0.08
Corticosteroids, mg/Kg/Daya0.95 (0.65–1.26)0.93 (0.69–1.18)0.66
PO2/FiO2, mmHg142.9 (123.2–162.5)124.9 (97.89–151.9)0.25
Mechanical ventilation duration, days7.6 (6.1–9.07)12.9 (11.06–14.73)<0.0001
Vt ml/Kgb5.80 (5.30–6.30)6.26 (6.02–6.51)0.058
Pplat, ICU Day 0, cmH2O22.85 (21.52–24.18)25.28 (23.89–26.66)0.04
Driving Pressure, ICU Day 0, cm H2O11.1 (10.3–11.9)13.02 (11.84–14.21)0.03
PEEP ICU Day 0, cmH2O10.54 (9.65–11.42)10.21 (9.52–10.90)0.38
PEEP >12 cmH2O (Day 0–7), hours43.53 (28.02–59.03)55.11 (41.30–68.92)0.28
Fluid Balance ICU Days 0–7, lit3.44 (1.17–5.71)6.17 (4.2–8.13)0.04
SARS-CoV-2 pneumonia, n (%)42 (68.8)54 (55.7)0.13
Temperature >38.5 °C, hours21.34 (10.99–31.70)28.19 (16.70–39.69)0.56
VAP, n (%)29 (47.5)33 (34)0.09
VAPc153 (17.31)191 (21.61)<0.0001
BSI, n (%)22 (36)46 (47.4)0.18
BSId116 (13.11)266 (30.06)0.001
Shock, n (%)20 (32.7)59 (60.8)0.001
Septic – VAP, n (%)4 (20)5 (8.5)
Septic – BSI, n (%)6 (30)16 (27.1)
Septic – VAP&BSI, n (%)6 (30)15 (25.4)
Unclear*, n (%)3 (15)24 (40.7)
ICU antibiotics course, dayse18.56 (15.78–21.34)16.55 (14.25–18.84)0.13
ICU mortality 28th day, n (%)6 (9.8)67 (69)<0.0001
ICU length of stay, days18.87 (16.17–21.56)17.25 (14.89–19.61)0.12

Characteristics of SARS-CoV2 ARDS patients according to weaning outcome_

Weaning Success (N=42)Weaning Failure (N=54)P Value
Age, years61.26 (57.12–65.41)68.98 (65.89–72.08)0.003
Men, n (%)28(66.7)33(61.1)0.67
APACHE II score ICU Day 014.38 (12.95–15.81)15.69 (14.34–17.03)0.15
SOFA score ICU Day 07.4 (6.80–8.09)8.2 (7.56–8.84)0.16
Heart failure, n (%)2 (4.7)7 (12.3)0.29
Diabetes mellitus, n (%)9 (21.4)17 (31.5)0.35
Hypertension, n (%)20 (47.6)27 (50)0.84
COPD, n (%)2 (4.8)11 (20.4)0.03
Immunosuppression, n (%)0 (0.0)6 (11.1)0.03
Corticosteroids, mg/kg/Daya1.13 (0.77–1.49)1.43 (1.07–1.80)0.29
PO2/FiO2, mmHg148.9 (123.8–174)106.1 (75.68–136.5)0.02
Mechanical ventilation duration, days7.59 (5.91–9.27)11.56 (9.17–13.92)0.006
Vt ml/Kgb5.80 (5.27–6.34)6.39 (6.18–6.11)0.13
Pplat, ICU Day 0, cmH2O22.67 (21.23–24.1)25.37 (23.91–26.88)0.016
Driving Pressure, ICU Day 0, cm H2O10.92 (10.11–11.72)13.02 (11.84–14.21)0.017
PEEP ICU Day 0, cmH2O11.45 (10.39–12.51)11.94 (11.13–12.76)0.63
PEEP >12 cmH2O (Day 0–7), hours61.5 (41.83–81.17)82.17 (62.55–101.7)0.11
Fluid Balance ICU Days 0–7, lit2.71 (−0.1–5.51)3.74 (1.17–5.80)0.3
Temperature >38.5°C, hours22.36 (10.88–33.83)14.56 (4.61–24.50)0.14
VAP, n (%)22 (53.6)15 (27.8)0.01
VAPc126 (19.35)110 (16.90)<0.0001
BSI, n (%)15 (36.6)25 (46.3)0.4
BSId86 (13.23)183 (28.15)0.02
Shock, n (%)12 (29.2)39 (72.2)<0.0001
VAP, n (%)3 (25)4 (10.2)
BSI, n (%)2 (16.6)11 (28.2)
VAP and BSI, n (%)5 (41.6)8 (20.5)
Unclear*, n (%)2 (16.6)15 (38.4)
ICU antibiotics course, dayse16.5 (13.86–19.14)13.13 (10.60–15.66)0.02
ICU mortality 28th day, n (%)4 (9.7)42 (77.8)<0.0001
ICU length of stay, days17.44 (14.87–20)13.65 (11.18–16.12)0.01

Results of binary regression analyses of risk factors associated with weaning success in SARS-CoV2 ARDS patients and ARDS patients

VariablesS.EP valueO.RLower 95% C.IUpper 95% C.I
SARS-CoV2 ARDS
COPD0.850.040.180.030.96
SOFA score0.110.170.860.691.06
Shock0.490.020.330.120.86
ARDS
COPD0.860.360.460.082.44
SOFA score0.110.070.820.661.01
Shock0.590.710.80.252.55

Results of binary regression analysis of risk factors associated with weaning success in the total population

VariablesS.EP valueO.RLower 95%C.IUpper 95% C.I
COPD0.610.030.270.080.89
SOFA score0.080.040.860.730.99
Shock0.370.0010.30.140.61
DOI: https://doi.org/10.2478/jccm-2023-0021 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 170 - 177
Submitted on: Oct 22, 2022
Accepted on: Jul 21, 2023
Published on: Jul 31, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Effrosyni Gerovasileiou, Apostolis-Alkiviadis Menis, George Gavriilidis, Eleni Magira, Prodromos Temperikidis, Sofia Papoti, Nikitas Karavidas, Michael Spanos, Epaminondas Zakynthinos, Demosthenes Makris, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.